Royal Biologics

OrthoBiologics and life science company

Based in NJ

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $90K in lobbying spend across 3 quarterly filings, Royal Biologics is an active lobbying client. Their lobbying covers 1 issue area.

$90K
Total Spend
1
Years Active
1
Firms Hired
2
Lobbyists Deployed
1
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2025$90K

Issues Lobbied

Medicare/Medicaid

Lobbying Firms

The Mcmanus Group

Lobbyists

John McmanusAlex Whalen

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid

  • •Issues related to coverage of and reimbursement for Human Cell & Tissue products, including Local Coverage Determination L39764- Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treat

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?

Related Investigations

Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

Glenmark Pharmaceuticals USA
$4.2M total spend
Sandoz INC
$2.4M total spend
FOX Rehabilitation
$1.6M total spend
Rwj Barnabas Health - FKA Barnabas Health
$1.5M total spend
Clover Health
$1.1M total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.